The problem of suicidality, personality disorder, and treatment: an alternative psycho-social perspective.

Marco Chiesa
Author Information
  1. Marco Chiesa: Department of Clinical, Educational & Health Psychology, University College London.

Abstract

suicidal behaviour, including both attempted and completed suicides, has been increasing globally, particularly in industrialized nations, making suicidality a significant public health concern. Despite the allocation of increasing resources by US, EU, and UK governmental and mental health bodies, the effectiveness of current strategies for the treatment, management, and prevention of suicide remains in question. This paper reviews evidence from epidemiological studies and national prevention policies, alongside research data from a London-based specialist personality disorder treatment centre and clinical case studies from private psychiatric/psychotherapy practice, to explore an alternative psychosocial approach to addressing suicidality. The dominant psychiatric model, which relies heavily on medication, hospitalization, and often coercive methods of control, may have iatrogenic effects, potentially exacerbating the risk of suicide. In contrast, a psychodynamic and psychosocial approach, focused on understanding the underlying psychological dimensions of suicidality, fostering a trusting therapeutic alliance, addressing both internal and external factors contributing to suicidal behaviour, and promoting open dialogue around suicidal thoughts, has shown promise in reducing suicide risk. The findings presented in this paper argue for a rethinking of traditional psychiatric approaches, advocating for a shift toward more personalized, collaborative, and psychologically informed interventions that can more effectively reduce the risk of suicide.

References

  1. Curr Psychiatry Rep. 2023 Sep;25(9):405-417 [PMID: 37642809]
  2. Clin Psychol Psychother. 2017 Nov;24(6):1331-1342 [PMID: 28748608]
  3. Australas Psychiatry. 2010 Oct;18(5):398-403 [PMID: 20863176]
  4. Am J Psychiatry. 2004 Aug;161(8):1463-70 [PMID: 15285974]
  5. Int J Qual Stud Health Well-being. 2018 Dec;13(1):1461514 [PMID: 29652227]
  6. Tidsskr Nor Laegeforen. 2018 Jun 12;138(10): [PMID: 29893100]
  7. Eur Neuropsychopharmacol. 2017 Apr;27(4):418-421 [PMID: 28161247]
  8. NCHS Data Brief. 2017 Dec;(293):1-8 [PMID: 29319473]
  9. Br J Psychiatry. 2000 May;176:485-91 [PMID: 10912227]
  10. Res Psychother. 2023 Nov 08;26(3): [PMID: 37946579]
  11. J Psychiatry Neurosci. 2003 Sep;28(5):331-7 [PMID: 14517576]
  12. Transl Psychiatry. 2016 Sep 13;6(9):e887 [PMID: 27622931]
  13. Res Psychother. 2022 Jun 30;25(2): [PMID: 35796595]
  14. J Pers Disord. 2004 Jun;18(3):240-7 [PMID: 15237044]
  15. NCHS Data Brief. 2016 Apr;(241):1-8 [PMID: 27111185]
  16. Psychotherapy (Chic). 2014 Sep;51(3):372-80 [PMID: 24773092]
  17. J Psychiatr Pract. 2014 Jan;20(1):63-7 [PMID: 24419312]
  18. J Epidemiol Community Health. 2021 Mar 08;: [PMID: 33685964]
  19. Epidemiol Psychiatr Sci. 2015 Apr;24(2):166-71 [PMID: 24576648]
  20. Bull Menninger Clin. 1946 May;10:66-70 [PMID: 20985168]
  21. Bull Menninger Clin. 2016 Winter;80(1):80-96 [PMID: 27028340]
  22. Br J Psychiatry. 1997 Mar;170:205-28 [PMID: 9229027]
  23. Soc Psychiatry Psychiatr Epidemiol. 2014 Sep;49(9):1353-5 [PMID: 25028199]
  24. Australas Psychiatry. 2011 Dec;19(6):507-12 [PMID: 22077302]
  25. Soc Psychiatry Psychiatr Epidemiol. 2014 Sep;49(9):1357-65 [PMID: 24647741]
  26. Lancet Psychiatry. 2016 Jul;3(7):646-59 [PMID: 27289303]
  27. Psychol Bull. 2017 Feb;143(2):187-232 [PMID: 27841450]
  28. Int J Law Psychiatry. 2013 Sep-Dec;36(5-6):339-42 [PMID: 23870280]
  29. Front Psychiatry. 2020 Jan 14;10:898 [PMID: 31992995]
  30. JAMA Netw Open. 2024 Jan 2;7(1):e2350963 [PMID: 38198136]
  31. Int J Soc Psychiatry. 2010 Jul;56(4):448-53 [PMID: 19651691]
  32. Psychother Psychosom. 2011;80(2):100-9 [PMID: 21196807]
  33. Br J Psychiatry. 1998 Dec;173:462-74 [PMID: 9926074]
  34. Borderline Personal Disord Emot Dysregul. 2023 Nov 1;10(1):32 [PMID: 37907967]
  35. Psychol Med. 2016 Jan;46(2):225-36 [PMID: 26370729]
  36. CMAJ. 2008 Jan 29;178(3):296-305 [PMID: 18227449]
  37. Australas Psychiatry. 2014 Apr;22(2):118-21 [PMID: 24288381]
  38. J Clin Psychiatry. 2012 Feb;73(2):144-51 [PMID: 21903026]
  39. Psychol Med. 2012 Nov;42(11):2383-94 [PMID: 22394511]
  40. JAMA Psychiatry. 2017 Jul 1;74(7):694-702 [PMID: 28564699]
  41. J Psychiatr Pract. 2009 Jan;15(1):12-24 [PMID: 19182561]
  42. Medicina (Kaunas). 2019 Jun 24;55(6): [PMID: 31238582]
  43. NCHS Data Brief. 2018 Jun;(309):1-8 [PMID: 30312151]
  44. Aust N Z J Psychiatry. 2004 Nov-Dec;38(11-12):933-9 [PMID: 15555028]

Word Cloud

Created with Highcharts 10.0.0suicidalitysuicideriskbehaviourincreasinghealthtreatmentpreventionpaperstudiespersonalitydisorderalternativepsychosocialapproachaddressingpsychiatricsuicidalSuicidalincludingattemptedcompletedsuicidesgloballyparticularlyindustrializednationsmakingsignificantpublicconcernDespiteallocationresourcesUSEUUKgovernmentalmentalbodieseffectivenesscurrentstrategiesmanagementremainsquestionreviewsevidenceepidemiologicalnationalpoliciesalongsideresearchdataLondon-basedspecialistcentreclinicalcaseprivatepsychiatric/psychotherapypracticeexploredominantmodelreliesheavilymedicationhospitalizationoftencoercivemethodscontrolmayiatrogeniceffectspotentiallyexacerbatingcontrastpsychodynamicfocusedunderstandingunderlyingpsychologicaldimensionsfosteringtrustingtherapeuticallianceinternalexternalfactorscontributingpromotingopendialoguearoundthoughtsshownpromisereducingfindingspresentedarguerethinkingtraditionalapproachesadvocatingshifttowardpersonalizedcollaborativepsychologicallyinformedinterventionscaneffectivelyreduceproblemtreatment:psycho-socialperspective

Similar Articles

Cited By

No available data.